Reversal of trauma-induced amnesia in mice by a thrombin receptor antagonist

Zeev Itzekson, Nicola Maggio, Anat Milman, Efrat Shavit, Chaim G. Pick, Joab Chapman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Minimal traumatic brain injury (mTBI) is associated with the existence of retrograde amnesia and microscopic bleeds containing activated coagulation factors. In an mTBI model, we report that thrombin induces amnesia through its receptor protease-activated receptor 1 (PAR-1). Thrombin activity was significantly elevated (32 %, p<0.05) 5 min following mTBI compared to controls. Amnesia was assessed by the novel object recognition test in mTBI animals and in animals injected intracerebroventricularly (ICV) with either thrombin or a PAR-1 agonist 1 h after the acquisition phase. Saline-injected controls had a preference index of over 0.3 while mTBI animals and those injected with thrombin or the PAR-1 agonist spent equal time with both objects indicating no recall of the object presented to them 24 h previously (p<0.05). Co-injecting a PAR-1 antagonist (SCH79797) completely blocked the amnestic effects of mTBI, thrombin, and the PAR-1 agonist. Long-term potentiation, measured in hippocampal slices 24 h after mTBI, ICV thrombin or the PAR-1 agonist, was significantly impaired and this effect was completely reversed by the PAR-1 antagonist. The results support a crucial role for PAR-1 in the generation of amnesia following mTBI, revealing a novel therapeutic target for the cognitive effects of brain trauma.

Original languageEnglish
Pages (from-to)87-95
Number of pages9
JournalJournal of Molecular Neuroscience
Issue number1
StatePublished - May 2014


  • Amnesia
  • Hippocampus
  • Long term potentiation
  • PAR1
  • Thrombin
  • mTBI


Dive into the research topics of 'Reversal of trauma-induced amnesia in mice by a thrombin receptor antagonist'. Together they form a unique fingerprint.

Cite this